Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review

Janus kinase (JAK) inhibitors have been developed as disease-modifying antirheumatic drugs. Despite the positive therapeutic impacts of JAK inhibitors, concerns have been raised regarding the risk of venous thromboembolism (VTE), such as deep vein thrombosis (DVT) and pulmonary embolism (PE). A rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Ogata, Fumihiko, Tsunoda, Ryusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458792/
https://www.ncbi.nlm.nih.gov/pubmed/34554329
http://dx.doi.org/10.1007/s10067-021-05911-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458792/
https://www.ncbi.nlm.nih.gov/pubmed/34554329
http://dx.doi.org/10.1007/s10067-021-05911-4

Ejemplares similares